Sol-Gel, Mayne Pharma Announce the Purchase of Epsolay and Twyneo in the U.S.
Sol-Gel Technologies, Ltd. and Mayne Pharma Group Limited are joining forces for the sale and exclusive license of the U.S. rights to Epsolay and Twyneo.
Day: April 17, 2025